Last reviewed · How we verify
NCT01119820
Tissue Donation for Myoblast Culture
NA trial testing Tissue Donation in Observe in Vitro Characteristics of Muscle Tissue in 24 participants. Completed in 1 June 2012.
1 February 2010
Quick facts
| Lead sponsor | University of California, Irvine |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 24 |
| Start date | 1 October 2008 |
| Primary completion | 1 February 2010 |
| Estimated completion | 1 June 2012 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Tissue Donation
Conditions studied
- Observe in Vitro Characteristics of Muscle Tissue — all drugs for Observe in Vitro Characteristics of Muscle Tissue →
- Elective Obstetric or Gynecologic Surgery — all drugs for Elective Obstetric or Gynecologic Surgery →
Sponsor
University of California, Irvine
Who can join
18 and older, female only, with Observe in Vitro Characteristics of Muscle Tissue or Elective Obstetric or Gynecologic Surgery. Patients with the condition only — healthy volunteers not accepted.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
cell expansion
Time frame: weekly
The goal of this pilot study is to obtain small amounts of human skeletal muscle that would normally be discarded during gynecologic surgery and instead conserve this tissue for laboratory analysis.
Sponsor's own description
Analyze human skeletal muscle and learn more about the ability of adult muscle to produce myoblasts (young muscle cells).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT01119820
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of California, Irvine trials
Trials by the same sponsor.
- NCT06952725 — Chatbot for Online Support Groups to Treat Tobacco Addiction · NA · not yet recruiting
- NCT07167862 — Optimizing Preeclampsia Postpartum With Point-of-care Ultrasound · Phase 4 · not yet recruiting
- NCT07527325 — Fianlimab&Cemiplimab as TotalNeoadj The (TNT) ForMelanoma · Phase 2 · not yet recruiting
- NCT07391891 — Musical Mindfulness for Pain in the ED Waiting Room · NA · not yet recruiting
- NCT07209917 — Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01119820 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of California, Irvine
- Last refreshed: 1 March 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01119820.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing